NIKAOTCPharmaceutical PreparationsFiscal year ends December 31
NIKA PHARMACEUTICALS, INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.41+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $431.19M
- P/E (TTM)
- –
- Dividend yield
- –
Nika Pharmaceuticals statistics
Financials through Jun 30, 2026, price as of Oct 16, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Nika Pharmaceuticals | Industry median |
|---|---|---|
| Market Cap | $431.19M | $166.30M |
| Enterprise Value | $431.53M | $88.19M |
Income (trailing twelve months)
| Measure | Nika Pharmaceuticals | Industry median |
|---|---|---|
| Operating Income | -$78.14K | -$21.40M |
| Pretax Income | -$78.14K | -$14.34M |
| Net Income | -$78.14K | -$22.46M |
| EBITDA | -$78.14K | -$16.91M |
| EPS (Diluted) | $0.00 | -$0.83 |
Returns
| Measure | Nika Pharmaceuticals | Industry median |
|---|---|---|
| Return on Assets (ROA) | -376.1% | -40.9% |
| Return on Invested Capital (ROIC) | -536.8% | -32.4% |
Balance sheet
| Measure | Nika Pharmaceuticals | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $2.93K | $61.43M |
| Total Debt | $340.62K | $118.52M |
| Net Cash (Debt) | -$337.69K | $15.35M |
| Net Cash Per Share | -$0.00 | $0.66 |
| Equity (Book Value) | -$330.68K | $49.09M |
| Book Value Per Share | -$0.00 | $1.37 |
| Tangible Book Value | -$330.68K | $23.52M |
| Working Capital | -$330.68K | $76.81M |
Financial position
| Measure | Nika Pharmaceuticals | Industry median |
|---|---|---|
| Current Ratio | 0.03 | 3.34 |
| Quick Ratio | 0.01 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Nika Pharmaceuticals | Industry median |
|---|---|---|
| Operating Cash Flow | -$69.14K | -$12.35M |
Dividends and yields
| Measure | Nika Pharmaceuticals | Industry median |
|---|---|---|
| Earnings Yield | -0.02% | -23.3% |
Shares
| Measure | Nika Pharmaceuticals | Industry median |
|---|---|---|
| Shares Outstanding | 1,051,690,000 | 58,127,000 |
| Shares Change (QoQ) | 0.30% | 0.54% |
| Float | 596,100,000 | 49,136,700 |
| Shares Held by Insiders | 43.3% | 11.6% |
Scores
| Measure | Nika Pharmaceuticals | Industry median |
|---|---|---|
| Altman Z-Score | -578.89 | -0.22 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Nika Pharmaceuticals's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.